with our research focus 'Infection and Immunity' and received many research funds for SARSCoV2 and COVID19 research. 101.4 million euros is considerable for a divisional university like the MHH, the only
and, more than any other scientist, represents the special role that science has to play during the COVID 19 pandemic - Professor Dr Christian Drosten, Director of the Institute of Virology at the Charité
Manns explained. "Our researchers have been active in and co-founded numerous networks on SARS-CoV-2/COVID-19. And our lecturers have successfully balanced presence and online teaching." Turnover of almost [...] centre in Germany, with 337 organ transplants in 2021." Patient care was significantly affected by COVID-19: "Last year we treated 239 people for a SARS-CoV-2 infection in an intensive care unit, almost [...] 97.2 million euros of acquired third-party funds on research. "The diverse research on SARS-CoV-2/COVID-19 contributed to this: since the beginning of the pandemic, our researchers have raised more than
developed for use in biomedical research. "These systems have also already been used, for example in COVID-19 research," says the scientist. The success of the research network is also reflected in the scientific
vaccines have been developed against the SARS-CoV-2 coronavirus. Effective drugs for a targeted COVID-19 treatment, on the other hand, do not yet exist. The research team led by Dr. Simon Krooss wants
people - for example, after transplantation or severe respiratory illnesses such as influenza or COVID-19 – the fungus can enter the lungs and cause aspergillosis. The infection is particularly difficult
by the federal government, the state of Lower Saxony, the Helmholtz Association and the HZI. "The COVID-19 pandemic has just shown us how important infection research and personalised medicine are - and
The complication often occurs with cardiovascular diseases or severe infectious diseases - such as COVID-19 - but also after operations, when taking drugs that are harmful to the kidneys or as a result of
(RNA) has found its way into medicine, at the latest with the development of vaccinations against COVID-19. But RNA can be used for more than just vaccinations. It is also a promising molecule for developing
developed for use in biomedical research. "These systems are also already being used, for example in COVID-19 research," says the scientist. The main areas of research in the first funding period were, for